Huma Therapeutics has been granted Class II clearance from the FDA for its Software-as-a-Medical-Device (SaMD) disease management platform, dramatically expanding the range of services it can deliver.
Researchers from IMDEA Materials Institute have demonstrated improved and more affordable catalytic materials used to produce ...
Raspberry Pi sent me a sample of their AI HAT+ 2 generative AI accelerator based on Hailo-10H for review. The 40 TOPS AI ...
Discover the leading database management systems for enterprises in 2026. Explore key features, pricing, and implementation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback